carbogen has been researched along with melphalan in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (57.14) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ara, G; Ha, CS; Herman, TS; Holden, SA; Northey, D; Teicher, BA | 1 |
| Herman, TS; Hopkins, RE; Menon, K; Teicher, BA | 1 |
| Bubley, G; Coleman, CN; Eder, JP; Frei, E; Herman, TS; Holden, SA; Tanaka, J; Teicher, BA | 1 |
| McIntosh-Lowe, NL; Rose, CM; Teicher, BA | 1 |
| Holden, SA; Jacobs, JL; Teicher, BA | 1 |
| Cathcart, KN; Crawford, JM; Holden, SA; Teicher, BA | 1 |
| Holden, SA; Rose, CM; Teicher, BA | 1 |
7 other study(ies) available for carbogen and melphalan
| Article | Year |
|---|---|
A new concentrated perfluorochemical emulsion and carbogen breathing as an adjuvant to treatment with antitumor alkylating agents.
Topics: Administration, Inhalation; Alkylating Agents; Animals; Antineoplastic Combined Chemotherapy Protocols; Carbon Dioxide; Carmustine; Cell Survival; Cyclophosphamide; Drug Administration Schedule; Drug Synergism; Emulsions; Fibrosarcoma; Fluorocarbons; Hematopoietic Stem Cells; Hydrocarbons, Brominated; Male; Melphalan; Mice; Mice, Inbred C3H; Neoplasm Transplantation; Oxygen; Tumor Cells, Cultured | 1992 |
Effect of a bovine hemoglobin preparation on the response of the FSaIIC fibrosarcoma to chemotherapeutic alkylating agents.
Topics: Alkylating Agents; Animals; Carbon Dioxide; Carmustine; Cattle; Cisplatin; Cyclophosphamide; Drug Synergism; Fibrosarcoma; Hemoglobins; Male; Melphalan; Mice; Mice, Inbred C3H; Oxygen | 1992 |
Modulation of alkylating agents by etanidazole and Fluosol-DA/carbogen in the FSaIIC fibrosarcoma and EMT6 mammary carcinoma.
Topics: Alkylating Agents; Animals; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carbon Dioxide; Carboplatin; Carmustine; Cell Survival; Colony-Forming Units Assay; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Combinations; Drug Synergism; Etanidazole; Fibrosarcoma; Flow Cytometry; Fluorocarbons; Hydroxyethyl Starch Derivatives; Mammary Neoplasms, Experimental; Melphalan; Mice; Nitroimidazoles; Organoplatinum Compounds; Oxygen; Radiation-Sensitizing Agents; Thiotepa | 1991 |
Effect of various oxygenation conditions and fluosol-DA on cancer chemotherapeutic agents.
Topics: Animals; Antineoplastic Agents; Bleomycin; Breast Neoplasms; Carbon Dioxide; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Drug Combinations; Fibrosarcoma; Fluorocarbons; Fluorouracil; Humans; Hydroxyethyl Starch Derivatives; Male; Melphalan; Methotrexate; Mice; Mice, Inbred C3H; Mice, Nude; Neoplasm Transplantation; Neoplasms; Organoplatinum Compounds; Oxygen; Tumor Cells, Cultured | 1988 |
Approaches to defining the mechanism of enhancement by Fluosol-DA 20% with carbogen of melphalan antitumor activity.
Topics: Animals; Bone Marrow; Carbon Dioxide; Cell Survival; DNA Damage; Drug Combinations; Fat Emulsions, Intravenous; Fluorocarbons; Hydroxyethyl Starch Derivatives; Kinetics; Male; Melphalan; Mice; Oxygen; Sarcoma, Experimental; Solubility; Tissue Distribution | 1987 |
Effects of various oxygenation conditions on the enhancement by Fluosol-DA of melphalan antitumor activity.
Topics: Animals; Carbon Dioxide; Cell Survival; Cells, Cultured; Drug Combinations; Drug Synergism; Fluorocarbons; Hydroxyethyl Starch Derivatives; Male; Melphalan; Mice; Neoplasms, Experimental; Oxygen; Spleen | 1987 |
Differential enhancement of melphalan cytotoxicity in tumor and normal tissue by Fluosol-DA and oxygen breathing.
Topics: Animals; Carbon Dioxide; Cell Survival; Drug Combinations; Drug Synergism; Fluorocarbons; Hematopoietic Stem Cells; Hydroxyethyl Starch Derivatives; Male; Melphalan; Mice; Mice, Inbred C3H; Neoplasms, Experimental; Oxygen; Respiration | 1985 |